相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。ALDH1A1+ ovarian cancer stem cells co-expressing surface markers CD24, EPHA1 and CD9 form tumours in vivo
Rohit P. Nagare et al.
EXPERIMENTAL CELL RESEARCH (2020)
CD9 in acute myeloid leukemia: Prognostic role and usefulness to target leukemic stem cells
Lucas Touzet et al.
CANCER MEDICINE (2019)
Tcf7l1 Acts as a Suppressor for the Self-Renewal of Liver Cancer Stem Cells and Is Regulated by IGF/MEK/ERK Signaling Independent of β-Catenin
Juanjuan Shan et al.
STEM CELLS (2019)
An emerging role of CD9 in stemness and chemoresistance
Mujib Ullah et al.
Oncotarget (2019)
CD9 identifies pancreatic cancer stem cells and modulates glutamine metabolism to fuel tumour growth
Victoria M. -Y. Wang et al.
NATURE CELL BIOLOGY (2019)
Phenotypic Plasticity: Driver of Cancer Initiation, Progression, and Therapy Resistance
Piyush B. Gupta et al.
CELL STEM CELL (2019)
Targeting Cancer Stemness in the Clinic: From Hype to Hope
Caner Saygin et al.
CELL STEM CELL (2019)
Tetraspanin CD9: A Key Regulator of Cell Adhesion in the Immune System
Raquel Reyes et al.
FRONTIERS IN IMMUNOLOGY (2018)
Measurable residual disease testing in acute myeloid leukaemia
C. S. Hourigan et al.
LEUKEMIA (2017)
CD99 is a therapeutic target on disease stem cells in myeloid malignancies
Stephen S. Chung et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
Improved outcomes for myeloid leukemia of Down syndrome: a report from the Children's Oncology Group AAML0431 trial
Jeffrey W. Taub et al.
BLOOD (2017)
Prognostic significance of flow-cytometry evaluation of minimal residual disease in children with acute myeloid leukaemia treated according to the AIEOP-AML 2002/01 study protocol
Barbara Buldini et al.
BRITISH JOURNAL OF HAEMATOLOGY (2017)
Transmembrane protein CD9 is glioblastoma biomarker, relevant for maintenance of glioblastoma stem cells
Neza Podergajs et al.
ONCOTARGET (2016)
Activated α2-Macroglobulin Regulates Transcriptional Activation of c-MYC Target Genes through Cell Surface GRP78 Protein
Udhayakumar Gopal et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
Assessment of Minimal Residual Disease in Standard-Risk AML
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Assessment of Minimal Residual Disease in Standard-Risk AML
A. Ivey et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
The role of VDR and BIM in potentiation of cytarabine-induced cell death in human AML blasts
Jonathan S. Harrison et al.
ONCOTARGET (2016)
T cells expressing CD123 chimeric antigen receptors for treatment of acute myeloid leukemia
Armen Mardiros et al.
CURRENT OPINION IN HEMATOLOGY (2015)
Acute Myeloid Leukemia
Hartmut Doehner et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Association of the EGF-TM7 receptor CD97 expression with FLT3-ITD in acute myeloid leukemia
Manja Wobus et al.
ONCOTARGET (2015)
Cancer stem cell plasticity and tumor hierarchy
Marina Carla Cabrera et al.
WORLD JOURNAL OF STEM CELLS (2015)
Tetraspanin CD9 modulates human lymphoma cellular proliferation via histone deacetylase activity
Michael J. Herr et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2014)
Tetraspanin proteins promote multiple cancer stages
Martin E. Hemler
NATURE REVIEWS CANCER (2014)
T cells expressing CD123-specific chimeric antigen receptors exhibit specific cytolytic effector functions and antitumor effects against human acute myeloid leukemia
Armen Mardiros et al.
BLOOD (2013)
Significance of minimal residual disease before myeloablative allogeneic hematopoietic cell transplantation for AML in first and second complete remission
Roland B. Walter et al.
BLOOD (2013)
High Prognostic Impact of Flow Cytometric Minimal Residual Disease Detection in Acute Myeloid Leukemia: Data From the HOVON/SAKK AML 42A Study
Monique Terwijn et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Prognostic and therapeutic implications of minimal residual disease detection in acute myeloid leukemia
Francesco Buccisano et al.
BLOOD (2012)
Comparative Analysis of Different Approaches to Measure Treatment Response in Acute Myeloid Leukemia
Hiroto Inaba et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
The tetraspanin CD9 regulates migration, adhesion, and homing of human cord blood CD34+ hematopoietic stem and progenitor cells
Kam Tong Leung et al.
BLOOD (2011)
Strategies for Homeostatic Stem Cell Self-Renewal in Adult Tissues
Benjamin D. Simons et al.
CELL (2011)
Monitoring of Minimal Residual Disease in NPM1-Mutated Acute Myeloid Leukemia: A Study From the German-Austrian Acute Myeloid Leukemia Study Group
Jan Kroenke et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Microenvironmental regulation of stem cells in intestinal homeostasis and cancer
Jan Paul Medema et al.
NATURE (2011)
Ferreting out stem cells from their niches
Elaine Fuchs et al.
NATURE CELL BIOLOGY (2011)
TIM-3 Is a Promising Target to Selectively Kill Acute Myeloid Leukemia Stem Cells
Yoshikane Kikushige et al.
CELL STEM CELL (2010)
Association of a Leukemic Stem Cell Gene Expression Signature With Clinical Outcomes in Acute Myeloid Leukemia
Andrew J. Gentles et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2010)
Identification of Therapeutic Targets for Quiescent, Chemotherapy-Resistant Human Leukemia Stem Cells
Yoriko Saito et al.
SCIENCE TRANSLATIONAL MEDICINE (2010)
CD9 correlates with cancer stem cell potentials in human B-acute lymphoblastic leukemia cells
Hiroko Nishida et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)
CD47 Is an Adverse Prognostic Factor and Therapeutic Antibody Target on Human Acute Myeloid Leukemia Stem Cells
Ravindra Majeti et al.
CELL (2009)
Monoclonal Antibody-Mediated Targeting of CD123, IL-3 Receptor α Chain, Eliminates Human Acute Myeloid Leukemic Stem Cells
Liqing Jin et al.
CELL STEM CELL (2009)
Berberine inhibits SDF-1-induced AML cells and leukemic stem cells migration via regulation of SDF-1 level in bone marrow stromal cells
Huiyu Li et al.
BIOMEDICINE & PHARMACOTHERAPY (2008)
Patterns of leukemia incidence in the United States by subtype and demographic characteristics, 1997-2002
Jennifer F. Yamamoto et al.
CANCER CAUSES & CONTROL (2008)
CD96 is a leukemic stem cell-specific marker in human acute myeloid leukemia
Naoki Hosen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Targeting of CD44 eradicates human acute myeloid leukemic stem cells
Liqing Jin et al.
NATURE MEDICINE (2006)
Binding of activated α2-macroglobulin to its cell surface receptor GRP78 in 1-LN prostate cancer cells regulates PAK-2-dependent activation of LIMK
UK Misra et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
The tetraspanin web modulates immune-signalling complexes
S Levy et al.
NATURE REVIEWS IMMUNOLOGY (2005)
分享论文
